Focuses on pediatric critical illness at the intersection of immunology and infection. Leverages multicenter clinical cohorts, data-driven subphenotyping, human genetics and proteomics to map immune dysregulation, stratify risk, and guide immunomodulatory and antimicrobial therapies.